AmberHealth vs Freya Meds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AmberHealth
Best for budget-conscious shoppersStarting at $100/mo
Freya Meds
Best for patients wanting dietitian-supported compounded GLP-1 programsStarting at $250/mo
Side-by-Side Comparison
| Feature | AmberHealth | Freya Meds |
|---|---|---|
| Overall Score | ✓7.7/10 | 7.0/10 |
| Starting Price | ✓$100/mo | $250/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.5 ★ /5 |
| Features | 3 features | ✓4 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
AmberHealth
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Freya Meds
Pros
- ✓Pure GLP-1 specialist — not a multi-category telehealth
- ✓Price includes unlimited doctor consultations, monthly group calls, and dietitian consultation
- ✓Both semaglutide and tirzepatide available
- ✓Multi-month discount on quarterly billing
- ✓Claims 450,000+ enrolled
Cons
- ✗No visible LegitScript or PCAB accreditation
- ✗Pricing is above average ($250–$390/mo) compared to competitors
- ✗Compounded only — no brand-name options
- ✗Specific state exclusions not disclosed
Our Verdict
AmberHealth edges out Freya Meds with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Freya Meds remains a solid alternative, especially if you're looking for patients wanting dietitian-supported compounded GLP-1 programs.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.